70/120
2.9 / 5 stars
All 120 Win/Lose results shown below
PDEX Roast Me summary
PRO DEX INC (PDEX). Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
- 2026-Q2: Total return Win; Revenue growth Win; EPS growth Win.
- 2026-Q1: Total return Win; Revenue growth Win; EPS growth Win.
- 2025-Q4: Total return Win; Revenue growth Win; EPS growth Win.
- 2025-Q3: Total return Lose; Revenue growth Win; EPS growth Win.
Trailing 1 year (4 quarters): 11 wins, 1 lossesLast fetched: 25 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q23/3 |
WinPDEX / S&P 19.20% / 15.20% |
WinPDEX / S&P 16.45% / 15.00% |
WinPDEX / S&P 54.31% / 50.40% |
| 2026-Q13/3 |
WinPDEX / S&P 27.65% / -4.33% |
WinPDEX / S&P 16.39% / 11.30% |
WinPDEX / S&P 29.75% / 27.70% |
| 2025-Q43/3 |
WinPDEX / S&P 13.68% / 2.65% |
WinPDEX / S&P 18.19% / 9.00% |
WinPDEX / S&P 70.00% / 13.40% |
| 2025-Q32/3 |
LosePDEX / S&P -22.43% / 8.12% |
WinPDEX / S&P 23.65% / 4.61% |
WinPDEX / S&P 118.95% / 13.45% |
| 2025-Q22/3 |
LosePDEX / S&P -11.98% / 10.94% |
WinPDEX / S&P 23.68% / 4.83% |
WinPDEX / S&P 345.00% / 10.63% |
| 2025-Q13/3 |
WinPDEX / S&P 6.05% / -4.27% |
WinPDEX / S&P 29.65% / 4.98% |
WinPDEX / S&P 372.88% / 10.57% |
| 2024-Q43/3 |
WinPDEX / S&P 56.62% / 2.41% |
WinPDEX / S&P 26.45% / 5.25% |
WinPDEX / S&P 135.29% / 6.15% |
| 2024-Q32/3 |
WinPDEX / S&P 51.99% / 5.89% |
WinPDEX / S&P 21.01% / 5.89% |
LosePDEX / S&P 4.79% / 6.11% |
| 2024-Q22/3 |
WinPDEX / S&P 11.59% / 4.28% |
WinPDEX / S&P 16.83% / 5.38% |
LosePDEX / S&P -69.23% / 5.12% |
| 2024-Q10/3 |
LosePDEX / S&P 0.46% / 10.56% |
LosePDEX / S&P 2.90% / 5.71% |
LosePDEX / S&P -71.77% / 5.59% |
| 2023-Q41/3 |
LosePDEX / S&P 11.59% / 11.69% |
WinPDEX / S&P 9.03% / 6.81% |
LosePDEX / S&P -51.70% / 7.78% |
| 2023-Q32/3 |
LosePDEX / S&P -17.80% / -3.27% |
WinPDEX / S&P 8.80% / 7.52% |
WinPDEX / S&P 15.87% / -5.03% |
| 2023-Q23/3 |
WinPDEX / S&P 16.39% / 8.74% |
WinPDEX / S&P 9.62% / 9.50% |
WinPDEX / S&P 61.16% / -8.57% |
| 2023-Q12/3 |
LosePDEX / S&P 3.21% / 7.50% |
WinPDEX / S&P 23.68% / 10.77% |
WinPDEX / S&P 117.71% / -15.69% |
| 2022-Q41/3 |
LosePDEX / S&P -10.27% / 7.56% |
LosePDEX / S&P 7.05% / 11.88% |
WinPDEX / S&P 27.54% / -17.99% |
| 2022-Q31/3 |
WinPDEX / S&P 11.10% / -4.88% |
LosePDEX / S&P 9.42% / 13.47% |
LosePDEX / S&P -19.75% / -1.41% |
| 2022-Q21/3 |
WinPDEX / S&P -3.51% / -16.10% |
LosePDEX / S&P 10.55% / 13.71% |
LosePDEX / S&P -22.93% / 11.04% |
| 2022-Q10/3 |
LosePDEX / S&P -28.78% / -4.60% |
LosePDEX / S&P -2.16% / 15.97% |
LosePDEX / S&P -49.21% / 42.23% |
| 2021-Q40/3 |
LosePDEX / S&P -9.58% / 11.03% |
LosePDEX / S&P 13.29% / 15.00% |
LosePDEX / S&P -16.36% / 96.40% |
| 2021-Q30/3 |
LosePDEX / S&P -16.00% / 0.58% |
LosePDEX / S&P 8.97% / 10.77% |
LosePDEX / S&P 3.29% / 69.42% |
| 2021-Q22/3 |
WinPDEX / S&P 13.40% / 8.55% |
WinPDEX / S&P 9.17% / 6.58% |
LosePDEX / S&P 4.67% / 51.81% |
| 2021-Q12/3 |
LosePDEX / S&P -12.98% / 6.17% |
WinPDEX / S&P 29.32% / -1.06% |
WinPDEX / S&P 71.82% / 7.39% |
| 2020-Q42/3 |
LosePDEX / S&P 8.29% / 12.15% |
WinPDEX / S&P 25.56% / -3.72% |
WinPDEX / S&P 70.10% / -33.42% |
| 2020-Q33/3 |
WinPDEX / S&P 60.49% / 8.93% |
WinPDEX / S&P 31.59% / -2.04% |
WinPDEX / S&P 61.70% / -27.10% |
| 2020-Q22/3 |
LosePDEX / S&P 10.00% / 20.54% |
WinPDEX / S&P 28.20% / -0.46% |
WinPDEX / S&P 54.64% / -27.11% |
| 2020-Q13/3 |
WinPDEX / S&P -7.69% / -19.60% |
WinPDEX / S&P 16.26% / 3.47% |
WinPDEX / S&P 39.24% / -14.75% |
| 2019-Q43/3 |
WinPDEX / S&P 14.71% / 9.07% |
WinPDEX / S&P 15.97% / 5.36% |
WinPDEX / S&P 32.88% / 2.99% |
| 2019-Q33/3 |
WinPDEX / S&P 17.87% / 1.70% |
WinPDEX / S&P 13.54% / 5.02% |
WinPDEX / S&P 77.36% / 0.21% |
| 2019-Q22/3 |
LosePDEX / S&P -10.36% / 4.30% |
WinPDEX / S&P 20.95% / 6.64% |
WinPDEX / S&P 162.16% / 8.65% |
| 2019-Q13/3 |
WinPDEX / S&P 19.87% / 13.65% |
WinPDEX / S&P 21.11% / 8.12% |
WinPDEX / S&P 51.92% / 14.29% |
| 2018-Q42/3 |
WinPDEX / S&P 16.15% / -13.52% |
WinPDEX / S&P 9.24% / 9.05% |
LosePDEX / S&P 15.87% / 18.23% |
| 2018-Q31/3 |
WinPDEX / S&P 56.39% / 7.71% |
LosePDEX / S&P PDEX unavailable / 10.21% |
LosePDEX / S&P -60.15% / 19.06% |
| 2018-Q20/3 |
LosePDEX / S&P -2.92% / 3.43% |
LosePDEX / S&P 2.38% / 9.03% |
LosePDEX / S&P -70.40% / 14.46% |
| 2018-Q11/3 |
WinPDEX / S&P 0.74% / -0.76% |
LosePDEX / S&P PDEX unavailable / 7.68% |
LosePDEX / S&P -53.57% / 12.46% |
| 2017-Q40/3 |
LosePDEX / S&P -6.21% / 6.64% |
LosePDEX / S&P PDEX unavailable / 7.03% |
LosePDEX / S&P -36.36% / 13.82% |
| 2017-Q32/3 |
WinPDEX / S&P 17.89% / 4.48% |
LosePDEX / S&P PDEX unavailable / 5.68% |
WinPDEX / S&P 343.33% / 17.57% |
| 2017-Q23/3 |
WinPDEX / S&P 33.70% / 3.09% |
WinPDEX / S&P 8.86% / 4.83% |
WinPDEX / S&P 525.00% / 17.74% |
| 2017-Q11/3 |
LosePDEX / S&P -2.13% / 6.07% |
LosePDEX / S&P PDEX unavailable / 3.67% |
WinPDEX / S&P 600.00% / 13.32% |
| 2016-Q41/3 |
LosePDEX / S&P 2.62% / 3.82% |
LosePDEX / S&P PDEX unavailable / 2.09% |
WinPDEX / S&P 1880.00% / 7.05% |
| 2016-Q30/3 |
LosePDEX / S&P -17.63% / 3.85% |
LosePDEX / S&P PDEX unavailable / 0.20% |
LosePDEX / S&P PDEX unavailable / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-28
| Metric | PDEX total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 32.94% | 20.78% |
| Annualized return | 32.94% | 20.78% |
5Y · 2021-09-01 to 2026-08-28
| Metric | PDEX total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 144.31% | 83.14% |
| Annualized return | 19.56% | 12.86% |
10Y · 2016-09-01 to 2026-08-28
| Metric | PDEX total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 1091.64% | 319.30% |
| Annualized return | 28.12% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-25.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 | |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |